SCHEMBL23199044

SCHEMBL23199044

COc1ccc2c(c1)C(=O)c1cc(CO)c(O)c(O)c1C2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.53
ELANE P08246 2/20 0.46
PGAM1 P18669 2/20 0.46
LCK P06239 3/20 0.45
PRKACA P17612 1/20 0.45
PRKACG P22612 1/20 0.45
PRKACB P22694 1/20 0.45
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
ACLY P53396 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
BCL2 P10415 1/20 0.41
MCL1 Q07820 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23198967 0.83 BCL2 (0.61) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL28232665 0.83 PTPN1 (0.60) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL436684 0.79 BCL2 (0.64) PTPN1ELANEPGAM1MAPTMEN1
SCHEMBL29066488 0.78 ACLY (0.52) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL16226807 0.77 ELANE (0.68) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL28872301 0.76 PTPN1 (0.55) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL2252533 0.75 CA1 (0.57) PTPN1LCKPRKACAPRKACGPRKACB
SCHEMBL7451901 0.75 CA1 (0.57) PTPN1LCKPRKACAPRKACGPRKACB
SCHEMBL16226415 0.74 PTPN1 (0.53) PTPN1ELANEPGAM1LCKPRKACA
SCHEMBL29173163 0.73 ESR1 (0.67) PTPN1LCKPRKACAPRKACGPRKACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3801507-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2021-04-14 EP claimed